Press "Enter" to skip to content

U.S. gov’t agrees to buy 100K doses of Eli Lilly antibody treatment

A healthcare worker drops blood for a rapid Covid-19 antibody test at the Southside Church of Christ in Los Angeles, California, on January 18, 2021 as free rapid Covid-19 antibody and PCR tests are administered to local residents in honor of Martin Luther King Jr. Day. (Photo by RINGO CHIU / AFP) (Photo by RINGO CHIU/AFP via Getty Images)

A healthcare worker drops blood for a rapid Covid-19 antibody test at the Southside Church of Christ in Los Angeles, California. (Photo by RINGO CHIU/AFP via Getty Images)

OAN Newsroom
UPDATED 5:00 PM PT – Friday, February 26, 2021

The U.S. government agreed to buy 100,000 doses of Eli Lilly’s COVID antibody therapy. According to that deal, which was announced Friday, the U.S. will pay $210 million for the doses.

Eli Lilly is expected to ship the doses out by the end of March. The treatment combines 700 mg of bamlanivimab and 1400 mg of etesevimab. The government will also have the option to buy 1.1 million more doses of the treatment through the end of November.

In November of 2020, Eli Lilly’s antibody cocktail received Emergency Use Authorization for use in high-risk COVID-19 patients.

MORE NEWS: Graham: Trump Will ‘Be Helpful’ To All Senate GOP Incumbents

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x